Indeed, amatuximab, a chimeric monoclonal anti-MSLN antibody, showed an enhanced anti-tumor effect of gemcitabine against mesothelin, highly expressing pancreatic cancer cell metastasis in a mouse model [27]. The gene discussed is MSLN; the disease is familial pancreatic carcinoma.